NRXPW
NRX Pharmaceuticals, Inc. - Warrant (NRXPW)
$02
About NRX Pharmaceuticals, Inc. - Warrant (NRXPW)
NRX Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded by Jonathan C. Javitt on September 18, 2017 and is headquartered in Wilmington, DE.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.18
52 Week Low
$0.01
Market cap
--
Dividend yield
0.00%
Volume
--
Avg. volume
26,712
P/E ratio
--
NRX Pharmaceuticals, Inc. - Warrant News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.18
52 Week Low
$0.01
Market cap
--
Dividend yield
0.00%
Volume
--
Avg. volume
26,712
P/E ratio
--